<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC"><gtr:id>D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC</gtr:id><gtr:name>Academic Medical Center (AMC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A67F0D66-6EB6-4F78-8AD7-2116C54EF353"><gtr:id>A67F0D66-6EB6-4F78-8AD7-2116C54EF353</gtr:id><gtr:name>Arthritis Research UK</gtr:name><gtr:address><gtr:line1>Copeman House</gtr:line1><gtr:line2>St Marys Court</gtr:line2><gtr:line3>St Marys Gate</gtr:line3><gtr:postCode>S41 7TD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E3FF571C-4ECF-478A-AA19-5F68DA0D9627"><gtr:id>E3FF571C-4ECF-478A-AA19-5F68DA0D9627</gtr:id><gtr:name>University of Zurich</gtr:name><gtr:address><gtr:line1>71,Raemistrasse</gtr:line1><gtr:line4>Zurich</gtr:line4><gtr:line5>CH 8006</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC"><gtr:id>D1A0DAB7-FD0B-415C-A58B-F4CFC655E3FC</gtr:id><gtr:name>Academic Medical Center (AMC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A67F0D66-6EB6-4F78-8AD7-2116C54EF353"><gtr:id>A67F0D66-6EB6-4F78-8AD7-2116C54EF353</gtr:id><gtr:name>Arthritis Research UK</gtr:name><gtr:address><gtr:line1>Copeman House</gtr:line1><gtr:line2>St Marys Court</gtr:line2><gtr:line3>St Marys Gate</gtr:line3><gtr:postCode>S41 7TD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E3FF571C-4ECF-478A-AA19-5F68DA0D9627"><gtr:id>E3FF571C-4ECF-478A-AA19-5F68DA0D9627</gtr:id><gtr:name>University of Zurich</gtr:name><gtr:address><gtr:line1>71,Raemistrasse</gtr:line1><gtr:line4>Zurich</gtr:line4><gtr:line5>CH 8006</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9ADE443D-30F8-4C9C-99F2-E333B81BFDC2"><gtr:id>9ADE443D-30F8-4C9C-99F2-E333B81BFDC2</gtr:id><gtr:firstName>Eric</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Jenkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9818340"><gtr:id>FC322B79-3A82-4C1A-97C8-F1AD88C342DD</gtr:id><gtr:title>MRC Centre for Immune Regulation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9818340</gtr:grantReference><gtr:abstractText>The immune system plays a vital role in protection against infectious disease caused by a range of micro-organisisms including viruses and bacteria. These responses are normally tightly regulated but when they run out of control they can also cause damage that leads to disease. These diseases include arthritis and inflammatory damage in the liver, kidneys and blood vessels which are a major contributor to the causes of ill health. It is therefore very important to understand how the immune response is regulated and controlled and what happens when this goes wrong. The MRC Centre brings together a series of internationally recognised research groups investigating different aspects of immune system control. These groups study basic mechanisms and apply this knowledge to selected diseases with the aim of identifying improved methods of treatment.</gtr:abstractText><gtr:technicalSummary>The mission of the Centre is to gain a better understanding of the regulation of the immune response with a view to developing strategies to augment beneficial responses and limit harmful responses leading to disease. The distinctive feature of research in the Centre, that unifies its component programmes, is its focus on microenvironmental factors controlling lymphocyte responses. Elucidation of these basic mechanisms is targeted to selected diseases with a particular focus on immune factors in auto-immune and inflammatory disease in joints, liver and kidney, and on chronic bacterial and viral infections in man. This is achieved by incorporation into the Centre of groups working on basic mechanisms alongside those investigating disease specific processes. In support of its mission, the Centre has the key aims of providing a well found research environment with state of the art technologies and a training environment in which young scientists and clinicians can gain experience in a wide range of cellular, molecular and in-vivo techniques in immunology. Existing strengths in the Centre focus on four areas of activity, mechanisms in lymphocyte development; induction and regulation of immunity in secondary lymphoid tissues; mechanisms in chronic inflammation; and cellular immunity to viral infection and tumours. To complement these, 3 new initiatives will be developed to add expertise in chemokine biology to the Centre s basic science programmes, to develop the capacity of the Centre to study the impact of ageing on the immune response and to develop the translation of Centre discoveries to therapeutic benefit.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>5648179</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of California, Berkeley</gtr:department><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>06AE2882-89C4-4BB9-BC86-478A9D82E181</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>343E4787-8CCF-43A0-B1DB-15CDB86B2AFE</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis Institutes for BioMedical Research (NIBR)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Novartis Vaccines Institute for Global Health (NVGH)</gtr:department><gtr:description>Adam Cunningam and Cal MacLennan Collaboration with Novartis Vaccines Institute for Global Health S.r.l.</gtr:description><gtr:id>A7552F1E-58AA-47BD-8C0B-4650B7493C3E</gtr:id><gtr:impact>PhD students registered at Birmingham but working at the Novartis Vaccines Institute. Calman MacLennan honarary Senior Lecturer at Birmingham now Head of the Exploratory programmes at the Vaccine's Institute but still has close ties with Birmingham and publishes papers of work supported by the MRC Centre</gtr:impact><gtr:partnerContribution>Potential funding and access to expertise in vaccine devlopment</gtr:partnerContribution><gtr:piContribution>Research in relation to the mechanisms of protective immunity to Salmonella and its derivative antigens, epidemiology and seroepidemiology of Salmonella and associated aspects; development of vaccines for typhoid, nontyphoidal Salmonella and Shigella.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Arthritis Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>964B0A8D-49C0-4148-853F-784CF265347D</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>3160FA5A-9BB2-44F7-8056-F287C39F143A</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zurich (Universit?t Z?rich UZH)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>0D5EF4FD-75F7-46F1-B738-A650A34DA4DC</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center (AMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>8E5C0118-51B1-4A69-9576-D70A0C1D1A47</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>FA037991-AAD9-40AF-B15A-1216A4D042BA</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>9EF67AAF-CE43-4570-AAFC-DC7B74502848</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>8ED3B99A-B048-4B3B-A9E6-8DF9BBB04E9B</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>MedImmune</gtr:department><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>ADF7C0D6-D135-4FFC-A4A5-D91E6D34E0DD</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>David Adams NIHR BIOMEDICAL RESEARCH LIVER UNIT</gtr:description><gtr:id>D76BFF96-A8C8-4F9C-A2EE-5ABBCB34E6A6</gtr:id><gtr:impact>Translational research on stem cell and immunotherapy in liver and liver cancer</gtr:impact><gtr:partnerContribution>research and clinical studies and trials</gtr:partnerContribution><gtr:piContribution>Research and clinical studies and trials</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Arthritis Research UK Centre of Excellence Rheumatoid Arthritis Centre of Excellence (RACE - Towards a Cure)</gtr:description><gtr:id>D1D95357-A48B-4A99-9A8E-0729238DE101</gtr:id><gtr:impact>Project being set up</gtr:impact><gtr:partnerContribution>The Glasgow hub in the Institute of Infection, Immunity and Inflammation (Director - IBM) will occupy the
Glasgow Biomedical Research Centre (http://www.gla.ac.uk/departments/gbrc) a &amp;pound;17 million 'new build'
containing 200 academic staff equipped with state-of-the art technology enabling molecular/cell biology
including e.g. dedicated FACS Facility, high throughput screening, dedicated Imaging Centre, including a
&amp;pound;1.5million investment in multi-photon imaging (PG/IBM), the recent &amp;pound;7 million investment in the Glasgow
Polyomics Facility (http://www.gla.ac.uk/colleges/mvls/research/gpf/) that offers superb Systems Medicine and
bioinformatics capabilities (lead by RB). GBRC hosts a EULAR Centre of Excellence.
The Newcastle hub will reside in the Institute of Cellular Medicine (http://www.ncl.ac.uk/icm/) comprising
some 180 research staff, and offering outstanding facilities for animal research include imaging, both
small-bore MRI and PET (Newcastle Imaging Centre), cell biology, molecular biology, epigenetics,
biochemistry and bioinformatics. The Musculoskeletal Research Group is a EULAR Centre of Excellence and
houses ARUK Centres of Excellence in Tissue Engineering and Musculoskeletal Ageing. Translational
research is focused in the Newcastle Clinical Research Facility
(http://www.ncl.ac.uk/business/facilities/research/clinicalresearch.htm).</gtr:partnerContribution><gtr:piContribution>The Birmingham hub will occupy the dedicated &amp;pound;8million laboratory/CRF space in the new Queen Elizabeth
&amp;quot;super&amp;quot; hospital (http://www.uhb.nhs.uk/new-hospital.htm). This includes the MRC-ARUK Center for
Musculoskeletal Ageing and the Experimental Arthritis Treatment Center (CB/JL). The IBR houses the MRC
Center for Immune Regulation (PL/GA) and provides state-of-the-art technologies, such as high throughput
sequencing, MoFlo cell sorting, through its Technology Hub. MRC Center for Immune Regulation:
http://www.birmingham.ac.uk/research/ activity/mds/centres/mrcimmune/index.aspx / Systems Science for
health. http:// www.birmingham.ac.uk/research/activity/ssfh/index.aspx/ Physical Sciences of Imaging in the
Biomedical Sciences http://www.birmingham.ac.uk/research/ activity/psibs/index.aspx.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Demonstrators on the STEMNET stand at the Big Bang Fair 2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A854968C-7DBB-4D96-B569-36C5ACEFF186</gtr:id><gtr:impact>Sonia Parnell and others from Graham Anderson's Immunology research Group had a very fulfilling time volunteering as activity demonstrators on the STEMNET stand at the Big Bang Fair 2014 recently. The investigative activities were family-focused and suitable for pre-schoolers through to adults. Sonia said she &amp;quot;found it a brilliant opportunity introducing young minds to scientific investigations&amp;quot;.




Over the past two years the Anderson/Jenkinson lab have organised 12 work placements in their laboratories in conjunction with King Edward VI and other secondary schools. This has been done in close partnership Julia Kingston, STEM Coordinator at the University of Birmingham STEM Centre. After the placements, Julia commented:

&amp;quot;Your students had a great experience. You and your group are doing a great job. Experiencing the actual lab environment is something they will never forget and it will certainly help them make up their minds [on a scientific career].&amp;quot;

Feedback from a sixth form student who undertook a lab placement wrote &amp;quot;&amp;quot;Thanks for the amazing experience.it gave me some food for thought about my EPQ (Extended Project Qualifications) research&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>01F8BFD3-A34F-484C-80E5-580A7B61FFE5</gtr:id><gtr:impact>Centre for Liver Research which is part of the MRC Centre for Immune Regulation took part in the Big Bang Fair on Saturday 17th March which was held at the NEC. This event is specifically aimed at children aged 5-18 years to show them how exciting science and engineering can be. 

29,000 children attended,The stand's activities included an 'I'm A Celebrity' style box that children could put their hands in and blindly feel a normal liver compared to a liver with cirrhosis (jelly filled with popcorn feels just like a cirrhotic liver). There was also a tunic with detachable organs that children had to stick back in the correct places and label and a celebrity quiz showing why Homer Simpson may have a liver problem.

Staff also participated in the MRC Bing Bang stand as volunteers.

Peter Balfe promoted the STEM Scheme and ran careers advice workshops</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits to talk about use of animals in research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C9923077-AC67-42C2-A8FC-D1CC8C311DAE</gtr:id><gtr:impact>Post-doctoral fellows based in the MRC Centre attended local schools to increase awareness amongst children of the use of animals in research

Increased understanding of why use of animals important</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WI talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4C2CC705-1859-4E44-BAFA-6100C7582644</gtr:id><gtr:impact>Group of 40 people attended talk on how medical research works and is funded.

Not yet known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BFF57071-3B35-487D-BAA7-0D281085B2AE</gtr:id><gtr:impact>Various activities by Centre members particularly in relation to Rheumatoid Arthritis, Liver Disease and ageing

More participation in patient groups and increased awareness of clinical trials for clinical trial recruitment</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rheumatology Research Patient Partners help shape nationally funded public awareness campaign for rheumatoid arthritis</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>243D09F8-56BA-4CF7-973B-014B6B2D188E</gtr:id><gtr:impact>Outcomes in rheumatoid arthritis (RA) are significantly improved if patients receive treatment within 12 weeks of the onset of symptoms, this is the conclusion of work borne from researchers at the University of Birmingham and elsewhere. 

The Rheumatology Research Group has been working hard to understand reasons for delay in patients with new onset RA seeing a Rheumatologist with a focus on understanding delays at the level of patients seeing their GP. Informed by this work, NHS England, Public Health England and the Department of Health have recently announced their decision to fund a pilot inflammatory arthritis awareness campaign.
 




The world-famous advertising company M&amp;amp;C Saatchi have been commissioned by the Government to work on this project and representatives have visited Birmingham to run a focus group with members of the Rheumatology Research Patient Partnership (R2P2) to discuss the development of the awareness raising material.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Immunology workshops in local schools</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F3D5D567-89D3-4C60-BE3B-6201D51C6307</gtr:id><gtr:impact>As part of a long standing and successful link with King Edward VI High School for Girls, Dr Adriana Flores-Langarica recently ran Immunology workshops with year 12 AS Biology groups who are looking to pursue careers in science or medicine. 

Adrianna is an experienced STEM ambassador and is passionate about inspiring our future generation of scientists and medics and each of her workshops really challenged the girls understanding of immunology. 


Increased understanding of an important area of research Mrs Janette Bagnall, Head of Biology, said &amp;quot;Adriana's questions to the girls demonstrated her careful scrutiny of the level of knowledge and understanding that should be expected at AS level Biology, whilst taking them beyond the confines of the specification to broaden their understanding of the topic&amp;quot;.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Commons and meetings with Science Minister</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9633F961-D174-4063-A6F5-E98E0FC39775</gtr:id><gtr:impact>Speaker to MPs at the BBSRC information event on Ageing research in the UK - at House of Commons in 2008(Janet Lord) and meetings with Science Minister and invited journalists for a discussion of the ageing population at the Royal Society in 2008.

Not known</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang event</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B84CB7DE-818C-481D-971D-C58A243A355F</gtr:id><gtr:impact>Various staff associated with MRC Centre participated as judges in the Big Bang event in Coventry. They were asked to judge a range of science projects from school children from across the West Midlands. The winners selected will all go through to a national final in London.

n/a</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>090AA77E-A9E9-4EBA-95DB-9B5CC88B28C6</gtr:id><gtr:impact>30 sixth form pupils attended talk on immunology and possible related career options and discussions with individual students

Not yet known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Agewell day to inform older adults about the research on ageing</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A5DDB7CE-799F-44C3-AE1F-35B2091E1C09</gtr:id><gtr:impact>Janet Lord ran her annual Agewell day to inform older adults about the research on ageing going on across the university. This year talks covered dementia, liver disease, how to keep a healthy weight and trauma. Despite the venue having a maximum capacity of 100, 130 elders turned 


n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Reigniting Regional Immunity; West Midlands BSI re-launch</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>113C1A64-2762-493B-88BA-AF85025143C0</gtr:id><gtr:impact>The West Midlands Regional Affinity Group has traditionally been a very strong local grouping organising. Three early career researchers based in the MRC Centre for Immune Regulation Dave Withers, Zania Stamataki and Will Jenkinson the group organised a conference paid for by teh BSI with invited speakers including Adrian Hayday, Tracy Hussell, Burkhard Ludewig, and early career researchers showcasing research in immune regulation.

New regionally focussed interactions and potential collaborations on Immune Regulation</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 2 page article in the guardian on &quot;How to live longer - the experts' guide to ageing&quot;</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7B3EDB0-7E4A-4E9C-A5C0-CF588A71E665</gtr:id><gtr:impact>Janet Lord featured prominently in a 2 page article in the guardian on &amp;quot;How to live longer - the experts' guide to ageing&amp;quot; The article also included work by PhD student Jerrald Rector about CMV, and Anna Phillips from Sports and exercise Sciences longehttp://www.theguardian.com/science/2013/sep/08/how-to-live-longer-experts-guide-ageingr-experts-guide-ageing

na</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://ongehttp://www.theguardian.com/science/2013/sep/08/how-to-live-longer-experts-guide-ageingr-experts-guide-ageing</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Birmingham Community Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BDA651AB-9511-4592-908A-7527D1937860</gtr:id><gtr:impact>Centre for Liver Research who had a range of fun activities for adults and children. Staff in the MRC Centre for Immune Regulation working on stem cells ranan informal discussion on ethics and the role of stem cells . It was a public engagement success for the University. Although we don't know the official figures, there looked to be several thousand attending.

 



Not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4 Events at British Science Festival 6-11 September 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1689FB91-B9E0-4167-835B-78605165F839</gtr:id><gtr:impact>Talk&amp;quot; Can you Prevent RA?&amp;quot;Rheumatoid arthritis is a common chronic disease. Whilst current treatments are unable to cure the disease, we are entering an era in which we may be able to prevent people developing the disease in the first place. This talk updated the public on some of the current developments relating to the latest research on what causes rheumatoid arthritis, predictive testing and preventive treatment. The talk sparked discussion about predictors of RA whether patients would like to know the they were likely to have the disease before symptoms became apparent and when in the life cycle would they like to be treated
&amp;quot;Your astonishing liver; Disease investigation to transplant innovation&amp;quot; informed the public about issues relating to liver disease, transplantation of livers, shortage of liver donors, new equipment being tested to recondition livers for transplant from patients who were not considered previously suitable as donors
&amp;quot;Use it or lose it&amp;quot; and &amp;quot;A cure for Ageing&amp;quot; promoted discussion on healthy ageing
&amp;quot;The first human cancer virus: A history&amp;quot; a talk by Alan Rickinson one of the founder directors of the MRC Centre for Immune Regulation recounted the fascinating story of the 50 years history since the Epstein-Barr virus (EBV) was discovered in a cancer in African children to how today EBV is linked to at least six different types of human cancer across the globe.



Greater understanding by those who attended of the diseases discussed and involovment of the public in research</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.britishscienceassociation.org/british-science-festival/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visits as part of world of work week</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6A2170FF-671A-4C73-9C7A-2743AECD668F</gtr:id><gtr:impact>Adriana Flores-Langarica and Jennifer Marshall from immunology, aided by undergraduate summer student Emma Dutton, visited Christ The King Primary School in Kingstanding as a part of their 'World of Work Week'.Two classes of year 6 pupils (10-11 years) were taught about the role and function of a scientist, the history of DNA and learnt how to extract DNA from kiwi and other fruits.

n/a</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MP pairing scheme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5DB7C0A3-B5B8-46F3-9BFD-56761CBACB15</gtr:id><gtr:impact>Participation in Royal Society MP Scientist Pairing Scheme (Adam Cunningham)

Not known</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Appointment grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802838</gtr:fundingRef><gtr:id>E7BD88DC-3E10-4D7F-A851-6DAC668D585A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7181445</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Infrastructure - Integrating innovative technologies for genotyping and phenotyping in stratified medicine</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M009157/1</gtr:fundingRef><gtr:id>09BE6FC6-37C1-46B6-9BE8-B6DC8BFD137E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1227858</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre for Musculoskeletal Ageing Research</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K00414X/1</gtr:fundingRef><gtr:id>D3A09AE2-BA62-4BC4-A335-3F896F01FD5A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Christopher Buckley: Birmingham Experimental Arthritis Treatment Centre for Rheumatoid Arthritis</gtr:description><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>20015</gtr:fundingRef><gtr:id>7A8596E0-AE26-434E-80EF-91594B310C97</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C4CE836-4D6C-4498-AB8E-B1EBAE01DADE"><gtr:id>9C4CE836-4D6C-4498-AB8E-B1EBAE01DADE</gtr:id><gtr:title>Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68859e2678f8b3f51bdc173b90573c7b"><gtr:id>68859e2678f8b3f51bdc173b90573c7b</gtr:id><gtr:otherNames>Rowe IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60B9D2B5-64C6-40C3-99FF-A0D2722F5AE4"><gtr:id>60B9D2B5-64C6-40C3-99FF-A0D2722F5AE4</gtr:id><gtr:title>Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47608de08e91ddb07b2d43a31809a80a"><gtr:id>47608de08e91ddb07b2d43a31809a80a</gtr:id><gtr:otherNames>Withers DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FFC3B8F-D068-4B16-829C-6549D76289D2"><gtr:id>8FFC3B8F-D068-4B16-829C-6549D76289D2</gtr:id><gtr:title>IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cabb205093b1d3a66cbb38c64024ddca"><gtr:id>cabb205093b1d3a66cbb38c64024ddca</gtr:id><gtr:otherNames>Wilkins C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31BCF43A-FB67-45B0-AC84-744FEF9989D0"><gtr:id>31BCF43A-FB67-45B0-AC84-744FEF9989D0</gtr:id><gtr:title>Static and dynamic assays of cell adhesion relevant to the vasculature.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a244f807ed1d6f0c6d6f79d10a3b867"><gtr:id>6a244f807ed1d6f0c6d6f79d10a3b867</gtr:id><gtr:otherNames>Butler LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FAA93954-2773-4EB2-8E3E-3A8407A32BF0"><gtr:id>FAA93954-2773-4EB2-8E3E-3A8407A32BF0</gtr:id><gtr:title>CD248 expression on mesenchymal stromal cells is required for post-natal and infection-dependent thymus remodelling and regeneration.</gtr:title><gtr:parentPublicationTitle>FEBS open bio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4eeb2d916603bac88cdc1b3ca0871f9f"><gtr:id>4eeb2d916603bac88cdc1b3ca0871f9f</gtr:id><gtr:otherNames>Lax S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2211-5463</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5348C53C-4B84-4F88-BCAD-6264613BFB2F"><gtr:id>5348C53C-4B84-4F88-BCAD-6264613BFB2F</gtr:id><gtr:title>Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/826cdc2ce0980c0b971111b73991889a"><gtr:id>826cdc2ce0980c0b971111b73991889a</gtr:id><gtr:otherNames>MacLennan CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD965A3F-C677-4715-B351-68AB141F52AA"><gtr:id>AD965A3F-C677-4715-B351-68AB141F52AA</gtr:id><gtr:title>Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f709a9e9b1fae073725cbf344e3ddb33"><gtr:id>f709a9e9b1fae073725cbf344e3ddb33</gtr:id><gtr:otherNames>O'Shaughnessy CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94720B5A-8AEA-4811-8E04-7B8FF14405EB"><gtr:id>94720B5A-8AEA-4811-8E04-7B8FF14405EB</gtr:id><gtr:title>Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e28545930847fbdf21015e10fbfd11d1"><gtr:id>e28545930847fbdf21015e10fbfd11d1</gtr:id><gtr:otherNames>Fletcher NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C114615A-65F0-43A6-9E93-AAF9DA78B048"><gtr:id>C114615A-65F0-43A6-9E93-AAF9DA78B048</gtr:id><gtr:title>Fibroblasts as novel therapeutic targets in chronic inflammation.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f450c313a516c0d5688f261bd7fc1b4"><gtr:id>9f450c313a516c0d5688f261bd7fc1b4</gtr:id><gtr:otherNames>Flavell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7063443-68AC-4A7A-9EED-DE7984A08FCF"><gtr:id>E7063443-68AC-4A7A-9EED-DE7984A08FCF</gtr:id><gtr:title>Stromal cells differentially regulate neutrophil and lymphocyte recruitment through the endothelium.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD241639-E807-4E65-B3EF-79A764AD81BE"><gtr:id>CD241639-E807-4E65-B3EF-79A764AD81BE</gtr:id><gtr:title>Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/18f98b1a657b99c07345bb4cbe726cc1"><gtr:id>18f98b1a657b99c07345bb4cbe726cc1</gtr:id><gtr:otherNames>Boumans MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D55559B5-A263-4659-80FA-6A7DD1B76DBE"><gtr:id>D55559B5-A263-4659-80FA-6A7DD1B76DBE</gtr:id><gtr:title>Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6022B8E8-293C-45D7-AD83-F67BD5E80925"><gtr:id>6022B8E8-293C-45D7-AD83-F67BD5E80925</gtr:id><gtr:title>Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CC64C9B-3474-4AAA-85F7-8E10DFB750ED"><gtr:id>7CC64C9B-3474-4AAA-85F7-8E10DFB750ED</gtr:id><gtr:title>Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fb8198871ffa3ada4c8c12e00fe628f"><gtr:id>4fb8198871ffa3ada4c8c12e00fe628f</gtr:id><gtr:otherNames>Horst D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6663F490-AF36-4D58-8EE9-89DC1C111BD6"><gtr:id>6663F490-AF36-4D58-8EE9-89DC1C111BD6</gtr:id><gtr:title>Expulsion of live pathogenic yeast by macrophages.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c64e7820c2cac5febc19e6b9d4ccb3d0"><gtr:id>c64e7820c2cac5febc19e6b9d4ccb3d0</gtr:id><gtr:otherNames>Ma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F24914C0-5F69-4906-AFBD-304EEE4146B4"><gtr:id>F24914C0-5F69-4906-AFBD-304EEE4146B4</gtr:id><gtr:title>Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0cdd91384fb465e3f2f206f98879c05"><gtr:id>a0cdd91384fb465e3f2f206f98879c05</gtr:id><gtr:otherNames>Mura M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7E3F8AF0-86B0-4D4E-B54C-F3942DC59D42"><gtr:id>7E3F8AF0-86B0-4D4E-B54C-F3942DC59D42</gtr:id><gtr:title>Checkpoints in the development of thymic cortical epithelial cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f173f6d7962bd161f7074229b69c801e"><gtr:id>f173f6d7962bd161f7074229b69c801e</gtr:id><gtr:otherNames>Shakib S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1673280D-43A7-4BC1-8681-A457988FB8D0"><gtr:id>1673280D-43A7-4BC1-8681-A457988FB8D0</gtr:id><gtr:title>Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2a4a04e268af9eecb879f27e8db28f62"><gtr:id>2a4a04e268af9eecb879f27e8db28f62</gtr:id><gtr:otherNames>Mutalithas K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06DD2DAF-9AD5-4851-BF03-217B55DBA81A"><gtr:id>06DD2DAF-9AD5-4851-BF03-217B55DBA81A</gtr:id><gtr:title>Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31b5002d2734f770c853e345f7f64ffe"><gtr:id>31b5002d2734f770c853e345f7f64ffe</gtr:id><gtr:otherNames>Ahmed SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D22FD9A7-AAAE-46CF-A677-FBA4E3FE4481"><gtr:id>D22FD9A7-AAAE-46CF-A677-FBA4E3FE4481</gtr:id><gtr:title>A role for the integrin alpha6beta1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bc31252be239b748664879198afe47d"><gtr:id>9bc31252be239b748664879198afe47d</gtr:id><gtr:otherNames>Haworth O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C62A16E2-A928-49D7-834C-4DE596585ECD"><gtr:id>C62A16E2-A928-49D7-834C-4DE596585ECD</gtr:id><gtr:title>The stability of complement-mediated bactericidal activity in human serum against Salmonella.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f709a9e9b1fae073725cbf344e3ddb33"><gtr:id>f709a9e9b1fae073725cbf344e3ddb33</gtr:id><gtr:otherNames>O'Shaughnessy CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79C51E67-6E17-44E0-A651-5AF2D218B033"><gtr:id>79C51E67-6E17-44E0-A651-5AF2D218B033</gtr:id><gtr:title>Differential requirement for CCR4 and CCR7 during the development of innate and adaptive a?T cells in the adult thymus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12cf8a53915af2fa89b82c348d13b6d7"><gtr:id>12cf8a53915af2fa89b82c348d13b6d7</gtr:id><gtr:otherNames>Cowan JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1A49FEE-247C-4263-9F39-75FFD31DBE05"><gtr:id>A1A49FEE-247C-4263-9F39-75FFD31DBE05</gtr:id><gtr:title>Influence of stromal cells on lymphocyte adhesion and migration on endothelial cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2981677-17F0-4ECA-897A-D6C16EA47860"><gtr:id>D2981677-17F0-4ECA-897A-D6C16EA47860</gtr:id><gtr:title>Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/704de06b92958737d590589fed939747"><gtr:id>704de06b92958737d590589fed939747</gtr:id><gtr:otherNames>Yeo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72DDE8B9-249B-471F-B302-A8238B903F53"><gtr:id>72DDE8B9-249B-471F-B302-A8238B903F53</gtr:id><gtr:title>A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de54615df428affa046bc044ae8d9416"><gtr:id>de54615df428affa046bc044ae8d9416</gtr:id><gtr:otherNames>Hislop AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FF0480E-01E0-4B4E-8AD3-EDDFDCC960F1"><gtr:id>9FF0480E-01E0-4B4E-8AD3-EDDFDCC960F1</gtr:id><gtr:title>HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86ff923ea25b951c739188c377e6136c"><gtr:id>86ff923ea25b951c739188c377e6136c</gtr:id><gtr:otherNames>Zona L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7BED4EF-DA17-425D-B3DD-7DCF679DCC9A"><gtr:id>F7BED4EF-DA17-425D-B3DD-7DCF679DCC9A</gtr:id><gtr:title>Innate lymphoid cells: the new kids on the block.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47608de08e91ddb07b2d43a31809a80a"><gtr:id>47608de08e91ddb07b2d43a31809a80a</gtr:id><gtr:otherNames>Withers DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F66DA4D5-9B21-4FEC-A45C-54C2485F2053"><gtr:id>F66DA4D5-9B21-4FEC-A45C-54C2485F2053</gtr:id><gtr:title>Natural Th17 cells are critically regulated by functional medullary thymic microenvironments.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/673c1fd2f788d7695b9d2a905d37fd23"><gtr:id>673c1fd2f788d7695b9d2a905d37fd23</gtr:id><gtr:otherNames>Jenkinson WE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55E21D5E-B0F7-4214-A36B-3636A3A7504A"><gtr:id>55E21D5E-B0F7-4214-A36B-3636A3A7504A</gtr:id><gtr:title>IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8722cf85af88fedef71a8a5f75ecdf1"><gtr:id>a8722cf85af88fedef71a8a5f75ecdf1</gtr:id><gtr:otherNames>Mohr E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A97DA87-69B7-44F3-A43B-5E2C2F77B52A"><gtr:id>4A97DA87-69B7-44F3-A43B-5E2C2F77B52A</gtr:id><gtr:title>The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12cf8a53915af2fa89b82c348d13b6d7"><gtr:id>12cf8a53915af2fa89b82c348d13b6d7</gtr:id><gtr:otherNames>Cowan JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C417A75-481D-43E3-9CD8-E87DF9732F4F"><gtr:id>9C417A75-481D-43E3-9CD8-E87DF9732F4F</gtr:id><gtr:title>Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C748F49-1F03-4E39-95A4-DBB7D569DD45"><gtr:id>2C748F49-1F03-4E39-95A4-DBB7D569DD45</gtr:id><gtr:title>Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f50d5673997b44c1d32c4f85330be839"><gtr:id>f50d5673997b44c1d32c4f85330be839</gtr:id><gtr:otherNames>Jeffery LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE3E2D49-AE60-4AE3-9ECA-C20DD55606E0"><gtr:id>BE3E2D49-AE60-4AE3-9ECA-C20DD55606E0</gtr:id><gtr:title>Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d79d6bb31b113551ddb534931c5a620"><gtr:id>4d79d6bb31b113551ddb534931c5a620</gtr:id><gtr:otherNames>Goodyear OC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88BA9106-C232-4F91-873A-979D09CD849A"><gtr:id>88BA9106-C232-4F91-873A-979D09CD849A</gtr:id><gtr:title>Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25fd330244e67263d95f007b9964721b"><gtr:id>25fd330244e67263d95f007b9964721b</gtr:id><gtr:otherNames>Hart PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51335101-A4C0-4DEA-AB5F-252072B252FA"><gtr:id>51335101-A4C0-4DEA-AB5F-252072B252FA</gtr:id><gtr:title>Modulation of endothelial responses by the stromal microenvironment: effects on leucocyte recruitment.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB6F8943-B008-467C-8FE4-DBB5D9F8FA3F"><gtr:id>CB6F8943-B008-467C-8FE4-DBB5D9F8FA3F</gtr:id><gtr:title>Role of CD30 in B/T segregation in the spleen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f5a81dcc15e7c7436b822c282b3f8f5"><gtr:id>0f5a81dcc15e7c7436b822c282b3f8f5</gtr:id><gtr:otherNames>Bekiaris V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/122A10A7-79EC-4EA7-97E2-FC0C907A20CD"><gtr:id>122A10A7-79EC-4EA7-97E2-FC0C907A20CD</gtr:id><gtr:title>Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8016d58bbcf460d195f65c2938961205"><gtr:id>8016d58bbcf460d195f65c2938961205</gtr:id><gtr:otherNames>Desanti GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C78963C-B1FA-418B-A5D4-33B42A9376EB"><gtr:id>3C78963C-B1FA-418B-A5D4-33B42A9376EB</gtr:id><gtr:title>Adhesion of tumor cells to matrices and endothelium.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/51d4d84575c75e28aaaa08f8d4b74642"><gtr:id>51d4d84575c75e28aaaa08f8d4b74642</gtr:id><gtr:otherNames>Yates CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/867FF6E2-B7E6-450B-B8D6-773A94AF1FCB"><gtr:id>867FF6E2-B7E6-450B-B8D6-773A94AF1FCB</gtr:id><gtr:title>MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc17541961a574382f3fd6e17b82a408"><gtr:id>dc17541961a574382f3fd6e17b82a408</gtr:id><gtr:otherNames>Long HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/302F5126-3808-4AFD-BDD9-648B18F23F64"><gtr:id>302F5126-3808-4AFD-BDD9-648B18F23F64</gtr:id><gtr:title>T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7B205E6-F03B-429C-8F98-FA04580F7AC0"><gtr:id>F7B205E6-F03B-429C-8F98-FA04580F7AC0</gtr:id><gtr:title>T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B2A737F-3AA6-453D-8193-B4160630C86C"><gtr:id>8B2A737F-3AA6-453D-8193-B4160630C86C</gtr:id><gtr:title>Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e25301d9343474ed0cb11fb61662443"><gtr:id>6e25301d9343474ed0cb11fb61662443</gtr:id><gtr:otherNames>Qureshi OS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1DF6D8E0-463C-4BE1-808F-1D008C67E168"><gtr:id>1DF6D8E0-463C-4BE1-808F-1D008C67E168</gtr:id><gtr:title>Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/45ee9f524afc1af2cb58609823aabd83"><gtr:id>45ee9f524afc1af2cb58609823aabd83</gtr:id><gtr:otherNames>Croft NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED6996E5-D96E-4AC4-9731-3006D9960008"><gtr:id>ED6996E5-D96E-4AC4-9731-3006D9960008</gtr:id><gtr:title>Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb9fbf0c961df1a49ef856f9ba745f74"><gtr:id>bb9fbf0c961df1a49ef856f9ba745f74</gtr:id><gtr:otherNames>Burton VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67A3346D-ECBB-49FD-BEE2-248DA47B7097"><gtr:id>67A3346D-ECBB-49FD-BEE2-248DA47B7097</gtr:id><gtr:title>ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/97afc826f99792379d9a5ce7c48ea5cb"><gtr:id>97afc826f99792379d9a5ce7c48ea5cb</gtr:id><gtr:otherNames>Biswas D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/908FF8B9-C461-4382-862F-E8EEA47EA258"><gtr:id>908FF8B9-C461-4382-862F-E8EEA47EA258</gtr:id><gtr:title>Thymus medulla fosters generation of natural Treg cells, invariant ?d T cells, and invariant NKT cells: what we learn from intrathymic migration.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12cf8a53915af2fa89b82c348d13b6d7"><gtr:id>12cf8a53915af2fa89b82c348d13b6d7</gtr:id><gtr:otherNames>Cowan JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6DA014A-1077-48A1-B6AA-2836C33473FC"><gtr:id>E6DA014A-1077-48A1-B6AA-2836C33473FC</gtr:id><gtr:title>Absence of thymus crosstalk in the fetus does not preclude hematopoietic induction of a functional thymus in the adult.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0512018dec985e4e9a09f7781c3ca4d"><gtr:id>e0512018dec985e4e9a09f7781c3ca4d</gtr:id><gtr:otherNames>Roberts NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BBC17DF-DE0F-46CA-8DB2-0EA8B94D20BB"><gtr:id>6BBC17DF-DE0F-46CA-8DB2-0EA8B94D20BB</gtr:id><gtr:title>Characterization of the yehUT two-component regulatory system of Salmonella enterica Serovar Typhi and Typhimurium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/acb24302b369f57434ca43459d2f3278"><gtr:id>acb24302b369f57434ca43459d2f3278</gtr:id><gtr:otherNames>Wong VK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6736A0CD-90C9-43CB-AFDA-3D2A7934465F"><gtr:id>6736A0CD-90C9-43CB-AFDA-3D2A7934465F</gtr:id><gtr:title>CCR7 Controls Thymus Recirculation, but Not Production and Emigration, of Foxp3(+) T Cells.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12cf8a53915af2fa89b82c348d13b6d7"><gtr:id>12cf8a53915af2fa89b82c348d13b6d7</gtr:id><gtr:otherNames>Cowan JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D04EB20D-BB11-44C6-8C33-9D1C39328756"><gtr:id>D04EB20D-BB11-44C6-8C33-9D1C39328756</gtr:id><gtr:title>The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af864607240255e91efccd46a80dec8d"><gtr:id>af864607240255e91efccd46a80dec8d</gtr:id><gtr:otherNames>Ulvmar MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8DB6007-7734-43F4-BAC4-7D1F5661D5B3"><gtr:id>A8DB6007-7734-43F4-BAC4-7D1F5661D5B3</gtr:id><gtr:title>CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/424da25bbe587e89ee3712f0b534778a"><gtr:id>424da25bbe587e89ee3712f0b534778a</gtr:id><gtr:otherNames>Stewart R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F56F8A1-7CFF-49F5-AA74-4E346E0035FA"><gtr:id>0F56F8A1-7CFF-49F5-AA74-4E346E0035FA</gtr:id><gtr:title>Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.</gtr:title><gtr:parentPublicationTitle>Microbial pathogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31c8a8dc16cf5f4ce845fdc9cfdad6ff"><gtr:id>31c8a8dc16cf5f4ce845fdc9cfdad6ff</gtr:id><gtr:otherNames>Rondini S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0882-4010</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8191BC7-3FF7-4AC2-B62B-202DFDDCD3C6"><gtr:id>C8191BC7-3FF7-4AC2-B62B-202DFDDCD3C6</gtr:id><gtr:title>Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to Salmonella.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2d119d2d28732637a596a12677acdfb"><gtr:id>c2d119d2d28732637a596a12677acdfb</gtr:id><gtr:otherNames>Gaspal F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD7FDC80-0C9F-4F2C-98D3-0629A618F8FA"><gtr:id>DD7FDC80-0C9F-4F2C-98D3-0629A618F8FA</gtr:id><gtr:title>Inflammation-induced formation of fat-associated lymphoid clusters.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85e0f1e9b568e36214ff9a0fef415598"><gtr:id>85e0f1e9b568e36214ff9a0fef415598</gtr:id><gtr:otherNames>B?n?zech C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F885F8E5-2390-4DFE-9DF5-16BDB7E16768"><gtr:id>F885F8E5-2390-4DFE-9DF5-16BDB7E16768</gtr:id><gtr:title>RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c88f9e243eee8735fccf734bf50cf212"><gtr:id>c88f9e243eee8735fccf734bf50cf212</gtr:id><gtr:otherNames>Rossi SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/676E05A4-07BF-4996-90D2-55325127F4CB"><gtr:id>676E05A4-07BF-4996-90D2-55325127F4CB</gtr:id><gtr:title>Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f9e48a67bd9da5b9eb13b4b681d16c4"><gtr:id>0f9e48a67bd9da5b9eb13b4b681d16c4</gtr:id><gtr:otherNames>McCarthy NI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/100A63C0-5323-414E-8505-8C33EAE16469"><gtr:id>100A63C0-5323-414E-8505-8C33EAE16469</gtr:id><gtr:title>Autophagy and immunity - insights from human herpesviruses.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8105854f6c79083a9dd41b0f14d6395f"><gtr:id>8105854f6c79083a9dd41b0f14d6395f</gtr:id><gtr:otherNames>Williams LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/38409DDE-932B-47E8-9313-987E272DE1C2"><gtr:id>38409DDE-932B-47E8-9313-987E272DE1C2</gtr:id><gtr:title>SadA, a trimeric autotransporter from Salmonella enterica serovar Typhimurium, can promote biofilm formation and provides limited protection against infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7f3c5ac0ed294dcd0579e4e10906042"><gtr:id>b7f3c5ac0ed294dcd0579e4e10906042</gtr:id><gtr:otherNames>Raghunathan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32F7ADA9-0E17-4270-A966-0D1E98FF73DE"><gtr:id>32F7ADA9-0E17-4270-A966-0D1E98FF73DE</gtr:id><gtr:title>OX40 controls effector CD4+ T-cell expansion, not follicular T helper cell generation in acute Listeria infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ceb4b798c8aa2274c466d04b9fcdb1a2"><gtr:id>ceb4b798c8aa2274c466d04b9fcdb1a2</gtr:id><gtr:otherNames>Marriott CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8FD6540-2FC2-4830-AF19-C52F2B34F702"><gtr:id>C8FD6540-2FC2-4830-AF19-C52F2B34F702</gtr:id><gtr:title>Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/085D8B06-8F23-4AE8-ADD3-5CBC4E36FF1C"><gtr:id>085D8B06-8F23-4AE8-ADD3-5CBC4E36FF1C</gtr:id><gtr:title>CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2ddf28a176bf0f756427edbddb9f2ee"><gtr:id>e2ddf28a176bf0f756427edbddb9f2ee</gtr:id><gtr:otherNames>Lucas B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB4ED790-3177-499A-A4EB-68538352A93A"><gtr:id>FB4ED790-3177-499A-A4EB-68538352A93A</gtr:id><gtr:title>Rank signaling links the development of invariant ?d T cell progenitors and Aire(+) medullary epithelium.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0512018dec985e4e9a09f7781c3ca4d"><gtr:id>e0512018dec985e4e9a09f7781c3ca4d</gtr:id><gtr:otherNames>Roberts NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C7B7BBD4-EFB8-4F7E-A29C-66D2AEF7DB23"><gtr:id>C7B7BBD4-EFB8-4F7E-A29C-66D2AEF7DB23</gtr:id><gtr:title>Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67e000b9b63dbeb08f7036e69e9d1799"><gtr:id>67e000b9b63dbeb08f7036e69e9d1799</gtr:id><gtr:otherNames>Wilhelm A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3485FBD-9A7E-471D-BBEA-AD3A8D221BAC"><gtr:id>D3485FBD-9A7E-471D-BBEA-AD3A8D221BAC</gtr:id><gtr:title>Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/493A82A0-34E4-45DF-B5AE-224F1D98A6E2"><gtr:id>493A82A0-34E4-45DF-B5AE-224F1D98A6E2</gtr:id><gtr:title>CCR7-dependent trafficking of ROR?? ILCs creates a unique microenvironment within mucosal draining lymph nodes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5c9ac55f62ee4c9c76c3a075393d3c"><gtr:id>ed5c9ac55f62ee4c9c76c3a075393d3c</gtr:id><gtr:otherNames>Mackley EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB52DF24-B81E-4A47-8A0A-2518E1CE98B1"><gtr:id>FB52DF24-B81E-4A47-8A0A-2518E1CE98B1</gtr:id><gtr:title>Mechanisms of thymus medulla development and function.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fa1360d4d0b741d199e016618d233b5"><gtr:id>5fa1360d4d0b741d199e016618d233b5</gtr:id><gtr:otherNames>Anderson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BF6D4AD-2E49-4B72-92FF-A3501D242AC4"><gtr:id>6BF6D4AD-2E49-4B72-92FF-A3501D242AC4</gtr:id><gtr:title>DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a67677116e4da306e94c57ba7effc80"><gtr:id>9a67677116e4da306e94c57ba7effc80</gtr:id><gtr:otherNames>Minten C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37B6B5F8-8C60-451F-94B3-546BA9CC5DDF"><gtr:id>37B6B5F8-8C60-451F-94B3-546BA9CC5DDF</gtr:id><gtr:title>The biochemistry and biology of the atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Immunology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f176dd01922419b3d1012bc2a4437f53"><gtr:id>f176dd01922419b3d1012bc2a4437f53</gtr:id><gtr:otherNames>Graham GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-2478</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06F42AB4-4C1C-48C5-BF98-495F01CA8868"><gtr:id>06F42AB4-4C1C-48C5-BF98-495F01CA8868</gtr:id><gtr:title>Analysis of leukocyte migration through monolayers of cultured endothelial cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db514f3de5ae34ad737a2d976461bbff"><gtr:id>db514f3de5ae34ad737a2d976461bbff</gtr:id><gtr:otherNames>McGettrick HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24C0B8EB-8BEF-439F-9E93-6283184FA7A0"><gtr:id>24C0B8EB-8BEF-439F-9E93-6283184FA7A0</gtr:id><gtr:title>Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/189e6bc991e4a601e3505b421420837d"><gtr:id>189e6bc991e4a601e3505b421420837d</gtr:id><gtr:otherNames>Smith E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B87D021A-6D3E-4929-8223-0C236DCA2A82"><gtr:id>B87D021A-6D3E-4929-8223-0C236DCA2A82</gtr:id><gtr:title>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D14E30A9-908C-46A1-A05E-988B85B7D081"><gtr:id>D14E30A9-908C-46A1-A05E-988B85B7D081</gtr:id><gtr:title>The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a9b5d379ff3f52541a2c3aa0109cd32"><gtr:id>1a9b5d379ff3f52541a2c3aa0109cd32</gtr:id><gtr:otherNames>Hardie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5ACB55AC-4070-4D36-8BFC-C87A3D913365"><gtr:id>5ACB55AC-4070-4D36-8BFC-C87A3D913365</gtr:id><gtr:title>Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b3c24374de29dcc05c743f4538117cb"><gtr:id>9b3c24374de29dcc05c743f4538117cb</gtr:id><gtr:otherNames>Chen YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF069302-8F80-4A97-9F0C-24E4E2EAA0A0"><gtr:id>AF069302-8F80-4A97-9F0C-24E4E2EAA0A0</gtr:id><gtr:title>Lymphotoxin a-dependent and -independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/713fd1506e897f8ddfa3facf6d1720f4"><gtr:id>713fd1506e897f8ddfa3facf6d1720f4</gtr:id><gtr:otherNames>White A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21E2A33B-4C2E-41D0-AF18-E9D118E426F4"><gtr:id>21E2A33B-4C2E-41D0-AF18-E9D118E426F4</gtr:id><gtr:title>Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dcb80ca8dcfba46d9f6a700959641e42"><gtr:id>dcb80ca8dcfba46d9f6a700959641e42</gtr:id><gtr:otherNames>Curnow SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48021803-25AA-4D7F-B86E-5C15EA4DECA4"><gtr:id>48021803-25AA-4D7F-B86E-5C15EA4DECA4</gtr:id><gtr:title>Identification of a common immune signature in murine and human systemic Salmonellosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c7a7d853c0a355edd143517f198f5e6"><gtr:id>8c7a7d853c0a355edd143517f198f5e6</gtr:id><gtr:otherNames>Lee SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2781CF62-E65D-41E3-8660-5A2113DD710A"><gtr:id>2781CF62-E65D-41E3-8660-5A2113DD710A</gtr:id><gtr:title>Resolving the problem of persistence in the switch from acute to chronic inflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bc31252be239b748664879198afe47d"><gtr:id>9bc31252be239b748664879198afe47d</gtr:id><gtr:otherNames>Haworth O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6420526-9976-42BC-B44B-3D50BF5B95F1"><gtr:id>F6420526-9976-42BC-B44B-3D50BF5B95F1</gtr:id><gtr:title>Inflammatory responses of endothelial cells experiencing reduction in flow after conditioning by shear stress.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47dc1cf88f20db1577cf560d663d5734"><gtr:id>47dc1cf88f20db1577cf560d663d5734</gtr:id><gtr:otherNames>Matharu NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E99519A-2794-48F0-9BDC-C82AEAEAEB9C"><gtr:id>3E99519A-2794-48F0-9BDC-C82AEAEAEB9C</gtr:id><gtr:title>Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/228b8552733022b0a8c1779f91099f6e"><gtr:id>228b8552733022b0a8c1779f91099f6e</gtr:id><gtr:otherNames>Siggins MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86A66E79-C256-4893-BF58-5DC794C4C041"><gtr:id>86A66E79-C256-4893-BF58-5DC794C4C041</gtr:id><gtr:title>The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d52775fac670e054cad28af8eb7a4b2c"><gtr:id>d52775fac670e054cad28af8eb7a4b2c</gtr:id><gtr:otherNames>Hidalgo E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/726165EF-595A-46F2-8F9D-348E33F94CAF"><gtr:id>726165EF-595A-46F2-8F9D-348E33F94CAF</gtr:id><gtr:title>Splenic stromal cells mediate IL-7 independent adult lymphoid tissue inducer cell survival.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85bd3bae78ebfd9614186f8b8e263206"><gtr:id>85bd3bae78ebfd9614186f8b8e263206</gtr:id><gtr:otherNames>Hou TZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/322016CF-7DAA-42D4-B0AA-161F808FFE43"><gtr:id>322016CF-7DAA-42D4-B0AA-161F808FFE43</gtr:id><gtr:title>Function of CD4+CD3- cells in relation to B- and T-zone stroma in spleen.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/efb06190e040b1cafccac06a8efdd770"><gtr:id>efb06190e040b1cafccac06a8efdd770</gtr:id><gtr:otherNames>Kim MY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/653441D5-6433-4C1A-8AE6-54B108AE0DA8"><gtr:id>653441D5-6433-4C1A-8AE6-54B108AE0DA8</gtr:id><gtr:title>Crosstalk between mesenchymal stem cells and endothelial cells leads to downregulation of cytokine-induced leukocyte recruitment.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ffbe9b161470158d3ebc6999f64dc2a"><gtr:id>7ffbe9b161470158d3ebc6999f64dc2a</gtr:id><gtr:otherNames>Luu NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5076FFA5-02D6-49DE-A943-07F3CF968739"><gtr:id>5076FFA5-02D6-49DE-A943-07F3CF968739</gtr:id><gtr:title>CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/36ebd950ca87257c96e33e2d2bfc27db"><gtr:id>36ebd950ca87257c96e33e2d2bfc27db</gtr:id><gtr:otherNames>Crompton L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97F853B5-526B-49E6-A631-622F466D2414"><gtr:id>97F853B5-526B-49E6-A631-622F466D2414</gtr:id><gtr:title>Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fee4aab7f4a265e7ca4a053ad7853da"><gtr:id>4fee4aab7f4a265e7ca4a053ad7853da</gtr:id><gtr:otherNames>Croudace JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0B1B9E8-3226-4F5B-9A25-D1EA4676AA16"><gtr:id>F0B1B9E8-3226-4F5B-9A25-D1EA4676AA16</gtr:id><gtr:title>Direct cell-to-cell spread of a pathogenic yeast.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c64e7820c2cac5febc19e6b9d4ccb3d0"><gtr:id>c64e7820c2cac5febc19e6b9d4ccb3d0</gtr:id><gtr:otherNames>Ma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/107E0EBE-F699-4132-B1A7-8264CCCAFF35"><gtr:id>107E0EBE-F699-4132-B1A7-8264CCCAFF35</gtr:id><gtr:title>The 5-deoxy-5-methylthio-xylofuranose residue in mycobacterial lipoarabinomannan. absolute stereochemistry, linkage position, conformation, and immunomodulatory activity.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ffff64d8a2ed3dad31667dc5b54e029"><gtr:id>8ffff64d8a2ed3dad31667dc5b54e029</gtr:id><gtr:otherNames>Joe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90134BF6-2B43-4966-B944-107DF6D28E09"><gtr:id>90134BF6-2B43-4966-B944-107DF6D28E09</gtr:id><gtr:title>Analysis of the effects of stromal cells on the migration of lymphocytes into and through inflamed tissue using 3-D culture models.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/36771a91799f743bb0de0cf4570ac721"><gtr:id>36771a91799f743bb0de0cf4570ac721</gtr:id><gtr:otherNames>Jeffery HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66827C7B-1F88-478F-AE55-5483BF39A516"><gtr:id>66827C7B-1F88-478F-AE55-5483BF39A516</gtr:id><gtr:title>Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa942592938ef63c6b125d9b1411314f"><gtr:id>aa942592938ef63c6b125d9b1411314f</gtr:id><gtr:otherNames>Schmutz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6DE5684F-F207-496D-A663-160DA57275BB"><gtr:id>6DE5684F-F207-496D-A663-160DA57275BB</gtr:id><gtr:title>Transient inhibition of ROR-?t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47608de08e91ddb07b2d43a31809a80a"><gtr:id>47608de08e91ddb07b2d43a31809a80a</gtr:id><gtr:otherNames>Withers DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC4C8B1D-998E-420C-A7F2-A1BB8F525228"><gtr:id>DC4C8B1D-998E-420C-A7F2-A1BB8F525228</gtr:id><gtr:title>An in vitro model for analysing neutrophil migration into and away from the sub-endothelial space: Roles of flow and CD31.</gtr:title><gtr:parentPublicationTitle>Biorheology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/605847a447e7f8075fa8cdb7fe82ffc3"><gtr:id>605847a447e7f8075fa8cdb7fe82ffc3</gtr:id><gtr:otherNames>Chakravorty SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-355X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/979C6C2A-0676-496D-BD4F-0DD9D27C3029"><gtr:id>979C6C2A-0676-496D-BD4F-0DD9D27C3029</gtr:id><gtr:title>Establishment and functioning of intrathymic microenvironments.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5fa1360d4d0b741d199e016618d233b5"><gtr:id>5fa1360d4d0b741d199e016618d233b5</gtr:id><gtr:otherNames>Anderson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE249446-4678-42F9-ACDC-7B4404B156E2"><gtr:id>CE249446-4678-42F9-ACDC-7B4404B156E2</gtr:id><gtr:title>Differential expression of CD148 on leukocyte subsets in inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/747c1648cdef8a591b01cdec5b71a4f8"><gtr:id>747c1648cdef8a591b01cdec5b71a4f8</gtr:id><gtr:otherNames>Dave RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8162BA52-EA3C-4A67-93EC-BA67BB3DC954"><gtr:id>8162BA52-EA3C-4A67-93EC-BA67BB3DC954</gtr:id><gtr:title>Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f5a81dcc15e7c7436b822c282b3f8f5"><gtr:id>0f5a81dcc15e7c7436b822c282b3f8f5</gtr:id><gtr:otherNames>Bekiaris V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D300376C-AF66-4E66-935B-20A1A5427008"><gtr:id>D300376C-AF66-4E66-935B-20A1A5427008</gtr:id><gtr:title>Atypical chemokine receptors.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af864607240255e91efccd46a80dec8d"><gtr:id>af864607240255e91efccd46a80dec8d</gtr:id><gtr:otherNames>Ulvmar MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D41B22FD-A0DF-4677-81D2-912431D05C29"><gtr:id>D41B22FD-A0DF-4677-81D2-912431D05C29</gtr:id><gtr:title>The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/879a5efbdff332a2d08dfb2e2258115b"><gtr:id>879a5efbdff332a2d08dfb2e2258115b</gtr:id><gtr:otherNames>Quinn LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D134FC03-1EA8-4548-80E5-3F6C0D5D9E20"><gtr:id>D134FC03-1EA8-4548-80E5-3F6C0D5D9E20</gtr:id><gtr:title>CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F384C0A-8C2C-4249-9466-6DFAF23BAF27"><gtr:id>6F384C0A-8C2C-4249-9466-6DFAF23BAF27</gtr:id><gtr:title>Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15).</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/efb06190e040b1cafccac06a8efdd770"><gtr:id>efb06190e040b1cafccac06a8efdd770</gtr:id><gtr:otherNames>Kim MY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9818340</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>